Goehring & Rozencwajg Associates LLC Purchases 45,199 Shares of Nutrien Ltd. $NTR

Goehring & Rozencwajg Associates LLC grew its position in shares of Nutrien Ltd. (NYSE:NTR) by 5.8% during the 4th quarter, Holdings Channel reports. The firm owned 825,437 shares of the company’s stock after purchasing an additional 45,199 shares during the period. Nutrien comprises 4.9% of Goehring & Rozencwajg Associates LLC’s investment portfolio, making the stock its 6th largest position. Goehring & Rozencwajg Associates LLC’s holdings in Nutrien were worth $50,946,000 at the end of the most recent quarter.

Several other hedge funds also recently modified their holdings of NTR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in shares of Nutrien by 65.1% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 25,224 shares of the company’s stock valued at $1,253,000 after purchasing an additional 9,950 shares during the period. NewEdge Advisors LLC increased its position in shares of Nutrien by 6.2% during the 1st quarter. NewEdge Advisors LLC now owns 6,907 shares of the company’s stock valued at $343,000 after purchasing an additional 404 shares during the period. Focus Partners Wealth acquired a new position in shares of Nutrien during the 1st quarter valued at $516,000. Acadian Asset Management LLC acquired a new position in shares of Nutrien during the 1st quarter valued at $54,000. Finally, Prudential Financial Inc. acquired a new position in shares of Nutrien during the 2nd quarter valued at $203,000. 63.10% of the stock is currently owned by institutional investors and hedge funds.

Nutrien Stock Performance

Shares of NYSE NTR opened at $67.65 on Friday. The company has a quick ratio of 0.59, a current ratio of 1.24 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $32.47 billion, a price-to-earnings ratio of 13.78, a PEG ratio of 0.60 and a beta of 0.60. The stock’s fifty day simple moving average is $71.34 and its 200 day simple moving average is $69.17. Nutrien Ltd. has a 52-week low of $53.03 and a 52-week high of $85.36.

Nutrien (NYSE:NTR) last issued its earnings results on Wednesday, May 6th. The company reported $0.51 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.48 by $0.03. The business had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $5.30 billion. Nutrien had a return on equity of 8.84% and a net margin of 8.58%.The company’s quarterly revenue was up 18.5% on a year-over-year basis. During the same period in the previous year, the firm posted $0.11 EPS. As a group, sell-side analysts forecast that Nutrien Ltd. will post 5.45 earnings per share for the current fiscal year.

Nutrien Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 17th. Stockholders of record on Tuesday, June 30th will be issued a dividend of $0.55 per share. The ex-dividend date is Tuesday, June 30th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 3.3%. Nutrien’s payout ratio is currently 44.81%.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on NTR. Scotiabank lifted their target price on Nutrien from $75.00 to $80.00 and gave the stock a “sector perform” rating in a report on Monday, May 11th. TD Securities restated a “buy” rating on shares of Nutrien in a report on Wednesday, May 6th. JPMorgan Chase & Co. lifted their target price on Nutrien from $78.00 to $80.00 and gave the stock an “overweight” rating in a report on Monday, May 11th. BMO Capital Markets lifted their target price on Nutrien from $85.00 to $90.00 and gave the stock an “outperform” rating in a report on Wednesday, March 18th. Finally, Royal Bank Of Canada lifted their target price on Nutrien from $80.00 to $85.00 and gave the stock an “outperform” rating in a report on Tuesday, April 7th. Eleven research analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Nutrien currently has an average rating of “Moderate Buy” and a consensus price target of $81.71.

Nutrien Profile

Nutrien Ltd. is a global fertilizer and agricultural-services company headquartered in Saskatoon, Saskatchewan, Canada. The company is publicly traded and operates across the farm input value chain, combining upstream fertilizer production with a broad retail and services platform aimed at supporting crop production worldwide. Nutrien’s business model integrates the manufacture and distribution of crop nutrients with on-the-ground agronomic support for growers and agricultural businesses.

Nutrien produces and supplies the three primary fertilizer nutrients—potash, nitrogen and phosphate—through its wholesale operations, and markets a wide range of crop inputs including seeds and crop protection products.